Role of IL-1 beta in the development of human T H17 cells: Lesson from NLPR3 mutated patients

Denise Lasigliè, Elisabetta Traggiai, Silvia Federici, Maria Alessio, Antonella Buoncompagni, Andrea Accogli, Sabrina Chiesa, Federica Penco, Alberto Martini, Marco Gattorno

Research output: Contribution to journalArticle

Abstract

Background: T helper 17 cells (T H-17) represent a lineage of effector T cells critical in host defence and autoimmunity. In both mouse and human IL-1β has been indicated as a key cytokine for the commitment to T H-17 cells. Cryopyrin-associated periodic syndromes (CAPS) are a group of inflammatory diseases associated with mutations of the NLRP3 gene encoding the inflammasome component cryopyrin. In this work we asked whether the deregulated secretion of IL-1β secondary to mutations characterizing these patients could affect the IL-23/IL-17 axis. Methodology/Principal Findings: A total of 11 CAPS, 26 systemic onset juvenile idiopathic arthritis (SoJIA) patients and 20 healthy controls were analyzed. Serum levels of IL-17 and IL-6 serum were assessed by ELISA assay. Frequency of T H17 cells was quantified upon staphylococcus enterotoxin B (SEB) stimulation. Secretion of IL-1β, IL-23 and IL-6 by monocyte derived dendritic cells (MoDCs), were quantified by ELISA assay. A total of 8 CAPS and 11 SoJIA patients were also analysed before and after treatment with IL-1β blockade. Untreated CAPS patients showed significantly increased IL-17 serum levels as well as a higher frequency of T H17 compared to control subjects. On the contrary, SoJIA patients displayed a frequency of T H17 similar to normal donors, but were found to have significantly increased serum level of IL-6 when compared to CAPS patients or healthy donors. Remarkably, decreased IL-17 serum levels and T H17 frequency were observed in CAPS patients following in vivo IL-1β blockade. On the same line, MoDCs from CAPS patients exhibited enhanced secretion of IL-1β and IL-23 upon TLRs stimulation, with a reduction after anti-IL-1 treatment. Conclusion/Significance: These findings further support the central role of IL-1β in the differentiation of T H17 in human inflammatory conditions.

Original languageEnglish
Article numbere20014
JournalPLoS One
Volume6
Issue number5
DOIs
Publication statusPublished - 2011

Fingerprint

Cryopyrin-Associated Periodic Syndromes
human development
interleukin-1
Human Development
Interleukin-1beta
Interleukin-1
T-lymphocytes
Interleukin-17
Interleukin-23
Juvenile Arthritis
arthritis
interleukin-6
Interleukin-6
Serum
secretion
dendritic cells
monocytes
Dendritic Cells
Monocytes
Assays

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Lasigliè, D., Traggiai, E., Federici, S., Alessio, M., Buoncompagni, A., Accogli, A., ... Gattorno, M. (2011). Role of IL-1 beta in the development of human T H17 cells: Lesson from NLPR3 mutated patients. PLoS One, 6(5), [e20014]. https://doi.org/10.1371/journal.pone.0020014

Role of IL-1 beta in the development of human T H17 cells : Lesson from NLPR3 mutated patients. / Lasigliè, Denise; Traggiai, Elisabetta; Federici, Silvia; Alessio, Maria; Buoncompagni, Antonella; Accogli, Andrea; Chiesa, Sabrina; Penco, Federica; Martini, Alberto; Gattorno, Marco.

In: PLoS One, Vol. 6, No. 5, e20014, 2011.

Research output: Contribution to journalArticle

Lasigliè, D, Traggiai, E, Federici, S, Alessio, M, Buoncompagni, A, Accogli, A, Chiesa, S, Penco, F, Martini, A & Gattorno, M 2011, 'Role of IL-1 beta in the development of human T H17 cells: Lesson from NLPR3 mutated patients', PLoS One, vol. 6, no. 5, e20014. https://doi.org/10.1371/journal.pone.0020014
Lasigliè D, Traggiai E, Federici S, Alessio M, Buoncompagni A, Accogli A et al. Role of IL-1 beta in the development of human T H17 cells: Lesson from NLPR3 mutated patients. PLoS One. 2011;6(5). e20014. https://doi.org/10.1371/journal.pone.0020014
Lasigliè, Denise ; Traggiai, Elisabetta ; Federici, Silvia ; Alessio, Maria ; Buoncompagni, Antonella ; Accogli, Andrea ; Chiesa, Sabrina ; Penco, Federica ; Martini, Alberto ; Gattorno, Marco. / Role of IL-1 beta in the development of human T H17 cells : Lesson from NLPR3 mutated patients. In: PLoS One. 2011 ; Vol. 6, No. 5.
@article{fc1e49dba3fe4690b79b35e237f2cd3a,
title = "Role of IL-1 beta in the development of human T H17 cells: Lesson from NLPR3 mutated patients",
abstract = "Background: T helper 17 cells (T H-17) represent a lineage of effector T cells critical in host defence and autoimmunity. In both mouse and human IL-1β has been indicated as a key cytokine for the commitment to T H-17 cells. Cryopyrin-associated periodic syndromes (CAPS) are a group of inflammatory diseases associated with mutations of the NLRP3 gene encoding the inflammasome component cryopyrin. In this work we asked whether the deregulated secretion of IL-1β secondary to mutations characterizing these patients could affect the IL-23/IL-17 axis. Methodology/Principal Findings: A total of 11 CAPS, 26 systemic onset juvenile idiopathic arthritis (SoJIA) patients and 20 healthy controls were analyzed. Serum levels of IL-17 and IL-6 serum were assessed by ELISA assay. Frequency of T H17 cells was quantified upon staphylococcus enterotoxin B (SEB) stimulation. Secretion of IL-1β, IL-23 and IL-6 by monocyte derived dendritic cells (MoDCs), were quantified by ELISA assay. A total of 8 CAPS and 11 SoJIA patients were also analysed before and after treatment with IL-1β blockade. Untreated CAPS patients showed significantly increased IL-17 serum levels as well as a higher frequency of T H17 compared to control subjects. On the contrary, SoJIA patients displayed a frequency of T H17 similar to normal donors, but were found to have significantly increased serum level of IL-6 when compared to CAPS patients or healthy donors. Remarkably, decreased IL-17 serum levels and T H17 frequency were observed in CAPS patients following in vivo IL-1β blockade. On the same line, MoDCs from CAPS patients exhibited enhanced secretion of IL-1β and IL-23 upon TLRs stimulation, with a reduction after anti-IL-1 treatment. Conclusion/Significance: These findings further support the central role of IL-1β in the differentiation of T H17 in human inflammatory conditions.",
author = "Denise Lasigli{\`e} and Elisabetta Traggiai and Silvia Federici and Maria Alessio and Antonella Buoncompagni and Andrea Accogli and Sabrina Chiesa and Federica Penco and Alberto Martini and Marco Gattorno",
year = "2011",
doi = "10.1371/journal.pone.0020014",
language = "English",
volume = "6",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Role of IL-1 beta in the development of human T H17 cells

T2 - Lesson from NLPR3 mutated patients

AU - Lasigliè, Denise

AU - Traggiai, Elisabetta

AU - Federici, Silvia

AU - Alessio, Maria

AU - Buoncompagni, Antonella

AU - Accogli, Andrea

AU - Chiesa, Sabrina

AU - Penco, Federica

AU - Martini, Alberto

AU - Gattorno, Marco

PY - 2011

Y1 - 2011

N2 - Background: T helper 17 cells (T H-17) represent a lineage of effector T cells critical in host defence and autoimmunity. In both mouse and human IL-1β has been indicated as a key cytokine for the commitment to T H-17 cells. Cryopyrin-associated periodic syndromes (CAPS) are a group of inflammatory diseases associated with mutations of the NLRP3 gene encoding the inflammasome component cryopyrin. In this work we asked whether the deregulated secretion of IL-1β secondary to mutations characterizing these patients could affect the IL-23/IL-17 axis. Methodology/Principal Findings: A total of 11 CAPS, 26 systemic onset juvenile idiopathic arthritis (SoJIA) patients and 20 healthy controls were analyzed. Serum levels of IL-17 and IL-6 serum were assessed by ELISA assay. Frequency of T H17 cells was quantified upon staphylococcus enterotoxin B (SEB) stimulation. Secretion of IL-1β, IL-23 and IL-6 by monocyte derived dendritic cells (MoDCs), were quantified by ELISA assay. A total of 8 CAPS and 11 SoJIA patients were also analysed before and after treatment with IL-1β blockade. Untreated CAPS patients showed significantly increased IL-17 serum levels as well as a higher frequency of T H17 compared to control subjects. On the contrary, SoJIA patients displayed a frequency of T H17 similar to normal donors, but were found to have significantly increased serum level of IL-6 when compared to CAPS patients or healthy donors. Remarkably, decreased IL-17 serum levels and T H17 frequency were observed in CAPS patients following in vivo IL-1β blockade. On the same line, MoDCs from CAPS patients exhibited enhanced secretion of IL-1β and IL-23 upon TLRs stimulation, with a reduction after anti-IL-1 treatment. Conclusion/Significance: These findings further support the central role of IL-1β in the differentiation of T H17 in human inflammatory conditions.

AB - Background: T helper 17 cells (T H-17) represent a lineage of effector T cells critical in host defence and autoimmunity. In both mouse and human IL-1β has been indicated as a key cytokine for the commitment to T H-17 cells. Cryopyrin-associated periodic syndromes (CAPS) are a group of inflammatory diseases associated with mutations of the NLRP3 gene encoding the inflammasome component cryopyrin. In this work we asked whether the deregulated secretion of IL-1β secondary to mutations characterizing these patients could affect the IL-23/IL-17 axis. Methodology/Principal Findings: A total of 11 CAPS, 26 systemic onset juvenile idiopathic arthritis (SoJIA) patients and 20 healthy controls were analyzed. Serum levels of IL-17 and IL-6 serum were assessed by ELISA assay. Frequency of T H17 cells was quantified upon staphylococcus enterotoxin B (SEB) stimulation. Secretion of IL-1β, IL-23 and IL-6 by monocyte derived dendritic cells (MoDCs), were quantified by ELISA assay. A total of 8 CAPS and 11 SoJIA patients were also analysed before and after treatment with IL-1β blockade. Untreated CAPS patients showed significantly increased IL-17 serum levels as well as a higher frequency of T H17 compared to control subjects. On the contrary, SoJIA patients displayed a frequency of T H17 similar to normal donors, but were found to have significantly increased serum level of IL-6 when compared to CAPS patients or healthy donors. Remarkably, decreased IL-17 serum levels and T H17 frequency were observed in CAPS patients following in vivo IL-1β blockade. On the same line, MoDCs from CAPS patients exhibited enhanced secretion of IL-1β and IL-23 upon TLRs stimulation, with a reduction after anti-IL-1 treatment. Conclusion/Significance: These findings further support the central role of IL-1β in the differentiation of T H17 in human inflammatory conditions.

UR - http://www.scopus.com/inward/record.url?scp=79957580938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957580938&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0020014

DO - 10.1371/journal.pone.0020014

M3 - Article

C2 - 21637346

AN - SCOPUS:79957580938

VL - 6

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e20014

ER -